Adolescents' descriptions of the physical characteristics of microbicide surrogates and experiences of use

Journal of Women's Health

Volumn 15, Issue 8, 2006, Pages 952-961

  Zubowicz, E Alexandra ^a   Oakes, Jennifer K ^a   Short, Mary B ^b   Perfect, Michelle M ^a   Succop, Paul S ^c   Rosenthal, Susan L ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF HOUSTON CLEAR LAKE   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICROBICIDE;

ADOLESCENT; ADULT; ANAMNESIS; ARTICLE; DEMOGRAPHY; DRUG FORMULATION; DRUG PREFERENCE; FEMALE; GEL; HUMAN; LUBRICATION; PERSONAL EXPERIENCE; PRIORITY JOURNAL; QUALITY CONTROL; SELF CONCEPT; SEMI STRUCTURED INTERVIEW; SEXUAL BEHAVIOR; SEXUAL COUNSELING; SEXUAL SATISFACTION; SEXUALITY; SUPPOSITORY; VAGINA PESSARY; WOMEN'S HEALTH;

ADMINISTRATION, INTRAVAGINAL; ADOLESCENT; ADOLESCENT BEHAVIOR; ADOLESCENT HEALTH SERVICES; ADULT; ANTI-INFECTIVE AGENTS, LOCAL; CONTRACEPTION BEHAVIOR; FEMALE; HEALTH BEHAVIOR; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; QUESTIONNAIRES; SEXUALLY TRANSMITTED DISEASES; VAGINAL CREAMS, FOAMS, AND JELLIES;

EID: 33751213893     PISSN: 15409996     EISSN: None     Source Type: Journal    
DOI: 10.1089/jwh.2006.15.952     Document Type: Article

References (32)

1. Center for Disease Control and Prevention. Adolescents and young adults. STD Surveillance 2004. Available at www.cdc.gov/std/stats/adol.htm Accessed November 1, 2005.
2. Cates JR, Herndon NL, Schulz SL, Darroch JE. Our voices, our lives, our futures: Youth and sexually transmitted diseases. Chapel Hill, NC: School of Journalism and Mass Communication, University of North Carolina at Chapel Hill, 2004.
3. Weinstock H, Berman S, Cates W. Sexually transmitted diseases among American youth: Incidence and prevalence estimates, 2000. Perspect Sex Reprod Health. 2004;36:6.
4. Holmes KK, Levine R, Weaver M. Effectiveness of condoms in preventing sexually transmitted infections. Bull WHO 2004;82:454.
5. Shlay JC, McClung MW, Patnaik JL, Douglas JM. Comparison of sexually transmitted disease prevalence by reported level of condom use among patients attending an urban sexually transmitted disease clinic. Sex Transm Dis 2004;31:154.
6. Wald A, Langenberg AGM, Krantz E, et al. The relationship between condom use and herpes simplex virus acquisition. Ann Intern Med 2005;143:707.
7. Manlove J, Ryan S, Franzetta K. Contraceptive use and consistency in U.S. teenagers' most recent sexual relationships. Perspect Sex Reprod Health 2004;36: 265.
8. National Institute of Allergy and Infectious Diseases. Topical microbicides: Preventing sexually transmitted diseases. Online Fact Sheet and Brochure. Available at www.niaid.nih.gov/Publications/ topical_microbicides.pdf Accessed November 1, 2005.
9. Rosenthal SL, Cohen SS, Stanberry LR. Topical microbicides: Current status and research considerations for adolescent girls. Sex Transm Dis 1998;25: 368.
10. Alliance for Microbicide Development. Ongoing microbicide clinical trials by phase. Available at secure.microbicide.org/NetReports/ ClinicalTrialsOngoingByPhase.aspx Accessed April 19, 2006.
11. Severy LJ, Tolley E, Woodsong C, Guest G. A framework for examining the sustained acceptability of microbicides. AIDS Behav 2005;9:121.
12. Mantell JE, Myer L, Carballo-Dieguz Alex, et al. Microbicide acceptability research: Current approaches and future directions. Soc Sci Med 2005;60:319.
13. Braunstein S, Van De Wijgert J. Preferences and practices related to vaginal lubrication: Implications for nucrobicide acceptability and clinical testing. J Wommens Health 2005;14:424.
14. Woodsong C. Covert use of topical microbicides: Implications for acceptability and use. Perspect Sex Reprod Health 2004;36:127.
15. Hardy E, Padua KS, Hebling EM, Osis MJD, Zaneveld LJD. Women's preferences for vaginal antimicrobial contraceptives. V: Attitudes of Brazilian women to the insertion of vaginal products. Contraception 2003;67:391.
16. Hardy E, Padua KS, Osis MJD, Jimenez AL, Zaneveld LJD. Women's preferences for vaginal antimicrobial contraceptives. IV: Attributes of a formulation that would protect from STD/AIDS. Contraception 1998;58:251.
17. Holt BY, Morwitz VG, Ngo L, et al. Microbicide preference among young women in California. J Womens Health 2006;15:281.
18. Richie L Spencer L. Qualitative data analysis for applied policy research. Analysing qualitative data. London: Routledge, 1994:173.
19. Short MB, Mills L, Majkowski JM, Stanberry LR, Rosenthal SL. Topical microbicide use by adolescent girls: Concerns about timing, efficacy, and safety. Sex Transm Dis 2003;30:854.
20. Short MB, Mills L, Majkowski JM, Stanberry LR, Rosenthal SL. Adolescent issues associated with knowledge of and access to topical microbicides. J Womens Health 2004;13:1127.
21. Morrow K, Rosen R, Richter L, et al. The acceptability of an investigational vaginal microbicide, PRO 2000 gel, among women in a phase I clinical trial. J Womens Health. 2003;12:655.
22. Hardy E, Jimenez AL, Padua KS, Zaneveld LJD. Women's preferences for vaginal antimicrobial contraceptives. III. Contraception 1998;58:245.
23. Helweg-Larsen M, Collins BE. The UCLA multidimensional condom attitudes scale: Documenting the complex determinants of condom use in college students. Health Psychol 1994;13:224.
24. Rosenthal SL, Cohen SS. Primary prevention of sexually transmitted disease: Self-efficacy in the context of sexual coercion. J Pediatric Adolesc Gynecol 1994;7:63.
25. Flood M. Lads in latex? Why young heterosexual men don't use condoms. Impact 2003;4:10.
26. Conley TD, Collins BE. Differences between condom users and condom nonusers in their multidimensional attitudes. J Appl Soc Psychol 2005;35:603.
27. Oncale RM, King BM. Comparison of men's and women's attempt to dissuade sexual partners from the couple using condoms. Arch Sex Behav 2001;30:379.
28. Mason TH, Foster SE, Finlinson HA, et al. Perspectives related to the potential use of vaginal microbicides among drug-involved women: Focus groups in three cities in the United States and Puerto Rico. AIDS Behav 2003;4:339.
29. Bentley ME, Morrow KM, Fullem A, et al. Acceptability of a novel vaginal microbicide during a safety trial among low-risk women. Fam Plann Perspect 2000;32:184.
30. Smith EJ. Will vaginal microbicides be acceptable? Network 2002;22:24.
31. Koo HP, Woodsong C, Dalberth BT, Viswanathan M, Simons-Rudolph A. Context of acceptability of topical microbicides: Sex Relationships 2005;61:67.
32. Garg S, Tambwekar KR, Vermani K, Garg A, Kaul CL, Zaneveld LJD. Compendium of pharmaceutical excipients for vaginal formulations. Pharm Tech 2001;25:14.